)
Visual
test
China Resources Boya Bio-pharmaceutical Group
China Resources Boya Bio-pharmaceutical Group (300294) investor relations material
China Resources Boya Bio-pharmaceutical Group H2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H2 2025 earnings summary21 Mar, 2026
Executive summary
Focused on blood products as core business, with gradual divestment of non-blood product operations.
Maintained stable supply of raw plasma and optimized production processes to ensure product quality and yield.
Completed the sale of 80% equity in the loss-making subsidiary Boyaxinhe to improve business focus.
Financial highlights
Revenue for 2025 was ¥2,059 million, up 18.69% year-over-year.
Net profit attributable to shareholders was ¥112.7 million, down 71.61% year-over-year.
Net profit excluding non-recurring items was -¥7.76 million, a significant decline from ¥301.6 million in 2024.
Operating cash flow was ¥61.2 million, down 79.60% year-over-year.
Fourth quarter net profit was negative due to impairment of intangible assets and goodwill.
Outlook and guidance
Strategic vision to become a world-class blood products company, with continued focus on core blood product business.
Ongoing construction of a smart factory to enhance production efficiency and quality.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from China Resources Boya Bio-pharmaceutical Group
- Revenue up, profit down YTD, cash flow pressured, Boya Xinhe deconsolidated.300294
Q3 202522 Dec 2025 - Revenue up 12.5% but net profit down 28.7% amid margin and policy pressures.300294H1 202522 Dec 2025
- Revenue up 19.49% but net profit down 8.25% as costs rise and cash flow turns negative.300294Q1 202522 Dec 2025
- Net profit jumped 67% to ¥397M as core blood products outperformed despite revenue decline.300294H2 202422 Dec 2025
- Revenue and profit fell on divestitures, but blood products and plasma supply expanded.300294Q3 202422 Dec 2025
- Revenue up 4.7% to RMB128.60b; net profit up 10.2%; major plasma acquisition, dividend declared.300294H1 202422 Dec 2025
China Resources Boya Bio-pharmaceutical Group
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage